MedPath

PARVOLEX LIQ IV 200MG/ML

PARVOLEX LIQ IV 200MG/ML

Discontinued
DIN Number

02094738

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

bioniche pharma (canada) ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02094738
AIG Number0100024001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R05CB01 ACETYLCYSTEINE
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification91:04.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

ACETYLCYSTEINEActive
Strength: 200 MG / ML
Monograph: ACETYLCYSTEINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.